The mean expression of PD–L1 and PD–L2 on CD14+ cells from patients with HCC who died was 58.1% and 62.3%, respectively; these patients almost all had PD–L1+PD–L2+CD14+ cells. This evidence concerns the gene CD14 and hepatocellular carcinoma.